SBIR-STTR Award

Independent Delivery Of Software-Enhanced Speech Therapy For Parkinson Disease
Award last edited on: 5/18/11

Sponsored Program
SBIR
Awarding Agency
NIH : NIDCD
Total Award Amount
$185,752
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Cynthia M Fox

Company Information

LSVT Global LLC

3323 North Campbell Avenue Suite 5
Tucson, AZ 85719
   (520) 867-8838
   info@lsvtglobal.com
   www.lsvtglobal.com
Location: Single
Congr. District: 06
County: Pima

Phase I

Contract Number: 1R43DC010956-01
Start Date: 8/18/10    Completed: 2/28/11
Phase I year
2010
Phase I Amount
$185,752
Independent access to efficacious voice treatment (LSVT LOUD) through technology is an essential solution to improving quality of life in individuals with PD. It can alleviate the barrier of inadequate numbers of clinicians, enhance feasibility of the essential intensive dose requirements, while relieving the physical burden of traveling to and from the clinic. LSVT LOUD is ideal for independent software applications as it is a standardized 16 session protocol with well-defined outcome measures. Implementation of our LSVT LOUD treatment software program (the LSVTC) for independent use for approximately 50% (7) of the treatment sessions, has demonstrated treatment outcome data comparable to 16 face-to-face treatment sessions with a clinician. Our next step in overcoming the accessibility bottleneck of a clinician shortage is to move toward a more fully independent treatment delivery model. As we move toward this model, one potential concern is that in the process of learning to improve vocal loudness, clients may exhibit unacceptable voice characteristics that an LSVT expert clinician would ""not allow to persist"" in face-to-face treatment. This Phase 1 proposal begins to address this issue by delineating the acoustic and electroglottographic characteristics of voices that LSVT LOUD expert clinicians would ""not allow to persist"" in treatment. These Phase l outcome data will be used in Phase II work to develop an algorithm for integration into LSVTC software that will detect unacceptable voice characteristics during client independent use, stop the client from using that unacceptable voice, and subsequently improve voice characteristics through feedback and modeling during independent practice. These Phase I and Phase II advances would be major technological milestones towards a continuum of technology-supported solutions that increase accessibility to efficacious speech treatment for individuals with PD. , ,

Public Health Relevance:
Nearly 90% of people with Parkinson disease have speech disorders that negatively affect quality of life as expressed by this patient: ""If I have no voice, I have no life."" Today, the first effective speech treatment (LSVT LOUD) is not accessible to the vast majority of patients because there are not enough speech clinicians to deliver it. This proposal will begin to advance a software version of that treatment (LSVT C) that ultimately will allow patients direct access to effective speech treatment and improved quality of life.

Thesaurus Terms:
Acoustic;Acoustics;Address;Affect;Algorithms;Behavior;Brain;Cns Plasticity;Characteristics;Client;Clinic;Clinical;Cognitive Discrimination;Comment;Comment (Pt);Comment [publication Type];Commentary;Commentary (Pt);Communication;Companions;Computer Programs;Computer Programs And Programming;Computer Software;Country;Data;Detection;Development;Discrimination;Discrimination (Psychology);Dose;Editorial Comment;Editorial Comment (Pt);Encephalon;Encephalons;Ensure;Exhibits;Family;Feedback;Foundations;Foxes;Frequencies (Time Pattern);Frequency;Frustration;Funding;Goals;Head And Neck, Larynx;Health;Home;Home Environment;Idiopathic Parkinson Disease;Image;Impairment;Individual;Institutes;Laryngeal;Larynx;Learning;Left;Lewy Body Parkinson Disease;Life;Loudness;Measures;Modeling;Motivation;Motor;Motor Skills;Movement;Nih;National Institutes Of Health;National Institutes Of Health (U.S.);Nervous;Nervous System, Brain;Neuronal Plasticity;Outcome;Outcome Measure;Paralysis Agitans;Parkinson;Parkinson Disease;Parkinson's;Parkinson's Disease;Parkinsons Disease;Patients;Phase;Physiologic;Physiological;Position;Positioning Attribute;Pressure;Pressure- Physical Agent;Primary Parkinsonism;Process;Production;Programs (Pt);Programs [publication Type];Protocol;Protocols Documentation;Published Comment;Publishing;Qol;Quality Of Life;Reporting;Sampling;Sensory;Software;Solutions;Sound;Sound - Physical Agent;Speech;Speech Disorders;Speech Intelligibilities;Speech Intelligibility;Speech Manifestations;Speech Therapy;Technology;Testing;Therapeutic;Time;Training;Travel;Treatment Outcome;United States National Institutes Of Health;Viewpoint;Viewpoint (Pt);Voice;Voice Disorders;Voice Quality;Work;Base;Body Movement;Computer Program;Computer Program/Software;Computer Programming;Dosage;Experience;Experiment;Experimental Research;Experimental Study;Imaging;Improved;Locomotor Learning;Motor Learning;Neural;Neural Plasticity;Neuroplasticity;Pressure;Programs;Public Health Relevance;Relating To Nervous System;Research Study;Respiratory;Skill Acquisition;Sober;Sobriety;Sound;Voice Box

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----